Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study

AIDS Patient Care and STDs

Volumn 21, Issue 11, 2007, Pages 833-841

  Orlando, G ^a   Guaraldi, G ^a   De Fazio, D ^b   Rottino, A ^b   Grisotti, A ^b   Blini, M ^b   De Santis, G ^c   Pedone, A ^c   Spaggiari, A ^c   Baccarani, A ^c   Vandelli, M ^c   De Paola, M ^c   Comelli, D ^c   Nardini, G ^a   Beghetto, B ^a   Squillace, N ^a   Esposito, R ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

POLYACRYLAMIDE; POLYLACTIC ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY IMAGE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ESTHETICS; FACE SURGERY; FACIAL LIPOATROPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID TRANSPORT; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PSYCHOMETRY; QUESTIONNAIRE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; ADAPTIVE BEHAVIOR; ECHOGRAPHY; HIV ASSOCIATED LIPODYSTROPHY; ITALY; MIDDLE AGED; OBSERVATION; PHOTOGRAPHY; PSYCHOLOGICAL ASPECT; SKIN DISEASE; TRANSPLANTATION;

ADAPTATION, PSYCHOLOGICAL; ADIPOSE TISSUE; BODY IMAGE; DEPRESSION; ESTHETICS; FACIAL DERMATOSES; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; ITALY; MALE; MIDDLE AGED; OBSERVATION; PATIENT SATISFACTION; PHOTOGRAPHY; PSYCHOMETRICS; TREATMENT OUTCOME;

EID: 41449102837     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0029     Document Type: Article

References (22)

1. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001;15:1389-1398.
2. Lichtenstein KA, Delaney KM, Armon C, et al. Development of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1 infected patients. J Acquir Immune Defic Syndr 2003;32:48-56.
3. Grinspoon S. Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome. Clin Infect Dis 2003;37(Suppl):S85-S90.
4. Schambelan M, Benson CA, Carr A, et al. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society - USA panel. J Acquir Immune Defic Syndr 2002;31:257-275.
5. Colins E, Wagner C, Walmsley S. Psychosocial impact of lipodystrophy syndrome in HIV infection. AIDS Reader 2000;10:546-551.
6. Huang JS, Lee D, Becerra K, Santos R, Barber ED, Mathews WC. Body image in men with HIV. AIDS Patient Care STDs 2006;20:668-677.
7. Mart(nez E, Garc(a-Viejo MA, Blanch J, et al. Lipodystrophy syndrome in patients with HIV infection: Quality of life issues. Drug Saf 2001;24:157-166.
8. Guaraldi G, Orlando G, Murri R, et al. Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. HIV Clin Trials 2003;4:99-106.
9. Corless IB, Kirksey KM, Kemppainen J, et al. Lipodystrophy-associated symptoms and medication adherence in HIV/AIDS. AIDS Patient Care STDs 2005;19:577-586.
10. Vamos M. Body image and chronic illness: A reconceptualisation. Int J Psych Med 1993;23:163-178.
11. Chapman L. Body image and HIV: Implications for support and care. AIDS Care 1998;(Suppl 10):S179-189.
12. Tate H, George R. The effect of weight loss on body image in HIV positive gay men. AIDS Care 2001;13:163-169.
13. Benn P, Sauret V, Cartledge J, et al. RAVE Facial Sub-Study. 3rd IAS Conference on HIV Pathogenesis and Treatment, 2005, Poster #TuPeLB2.3C02.
14. Guaraldi G, Orlando G, De Fazio D, et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: A prospective study. Antivir Ther 2005;10:753-759.
15. Guaraldi G, Orlando G, Squillace N, et al. Multidisciplinary approach to the Treatment of metabolic and morphologic alterations of HIV-related lipodistrophy. HIV Clin Trials 2006;7:97-106.
16. Guaraldi G, Orlando G, Murri R, et al. Quality of life and body image in the assessment of psychological impact of lipodystrophy: Validation of the Italian version of Assessment of Body Change and Distress questionnaire. Qual Life Res 2006;15:173-178.
17. Beck AT, Steer RA, Garbin MG, Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
18. Brown C, Schulberg HC, Madonia MJ. Assessing depression in primary care practice with the Beck Depression Inventory and the Hamilton Rating Scale for Depression. Psychol Assess 1995;7:59-65.
19. Barton SE, Engelhard E, Conant M. Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: A review of the clinical studies. Int J STD AIDS 2006;17:429-435.
20. Negredo E, Higueras C, Adell X, et al. Reconstructive treatment for antiretroviral-associated facial lipoatrophy: A prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDs 2006;20:829-837.
21. Guaraldi G, Orlando G, Orlando E, et al. Body Image perception in HIV-infected women with lipodystrophy syndrome. 2nd European Workshop on lipodystrophy Cannes 19-21/4/01 Abstract book P-58, p. 29.
22. Guaraldi G, Orlando G, Murri R, et al. Body image perception tests for lipodistrophy. Antiviral therapy 2001;6(Suppl 4):Abstract P67.